Welcome to IntraCross Medical
At IntraCross Medical we are strongly committed in revolutionizing and expanding upon already existing intraluminal treatments.
Providing swift and effective solutions to those in need is our vision, offering advancements previously unavailable.
Breakthrough Technology Platform:
Balloon Mobility
The IntraCross Platform is based on a groundbreaking technology. For the first time we enable catheter balloon mobility. This patent has the potential to greatly improve existing products and create entirely new surgical tools, broadening its impact across multiple medical fields.
Treatment of Peripheral Artery Disease (PAD) and Chronic Total Occlusions (CTOs)
As a first step with our revolutionary catheter design, we aim to address one of the most urgent challenges in modern healthcare—Peripheral Artery Disease (PAD) and Chronic Total Occlusions (CTOs), conditions that can progress to a more severe state known as Critical Limb Ischemia (CLI).
Our IntraCross Catheter redefines the possibilities of vascular surgery. We envision a future where nearly all vascular patients can benefit from minimally invasive endovascular procedures, ensuring optimal outcomes and enhancing their quality of life.
Prevalence of CLI
Peripheral chronic total occlusions (CTOs) are a significant concern in the management of peripheral artery disease (PAD), contributing to critical limb ischemia (CLI) and increasing the risk of limb loss.
Ref.: Fereydooni et al
IntraCross Catheter Benefits to the Industry
IntraCross Medical introduces a new era in managing the toughest CTO cases.
Key Achievements & Recognitions
Our team comprises a lean, experienced, multidisciplinary executive group and advisors with extensive expertise in the healthcare system locally and internationally.
